Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

33 results
Display

Hyponatremia after Radioactive Iodine Treatment in Thyroid Cancer Patients

Kwon OC, Lee HH, Oh KH, Kim TY

Radioactive iodine treatment (RAIT) after surgery reduces local recurrence and cancer related death. Cases of hyponatremia after preparation for RAIT have rarely been reported. We report 4 cases of hyponatremia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer

Mu ZZ, Zhang X, Lin YS

Most differentiated thyroid cancer (DTC) patients have an excellent prognosis. However, about one-third of DTC patients with recurrent or metastatic disease lose the hallmark of specific iodine uptake initially or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of relapsed hyperthyroidism

Chung JH

Graves disease is the most common disease that causes hyperthyroidism. It is an autoimmune disease characterized by the overproduction of thyroid hormones due to continuous stimulation of the thyroid gland...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lesionalized Therapy beyond Personalized Therapy in Cancer Management

Chung JK, Kim MJ, Youn H

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of a Low Iodine Diet vs. Restricted Iodine Diet on Postsurgical Preparation for Radioiodine Ablation Therapy in Thyroid Carcinoma Patients

Lim CY, Kim JY, Yoon MJ, Chang HS, Park CS, Chung WY

PURPOSE: The radioiodine ablation therapy is required for patients who underwent a total thyroidectomy. Through a comparative review of a low iodine diet (LID) and a restricted iodine diet (RID),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Normal Gallbladder Visualization during Post-Ablative Iodine-131 Scan of Thyroid Cancer

Seok JW, Kim SJ, Kim IJ, Kim YS, Kim YK

Whole body iodine-131 scan is a well-established imaging method for the detection of metastatic or residual tumor sites in patients with well-differentiated thyroid cancer. Many false-positive iodine-131 scan findings mimicking...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug-induced liver injury caused by iodine-131

Kim CW, Park JS, Oh SH, Park JH, Shim HI, Yoon JW, Park JS, Hong SB, Kim JM, Le TB, Lee JW

Iodine-131 is a radioisotope that is routinely used for the treatment of differentiated thyroid cancer after total or near-total thyroidectomy. However, there is some evidence that iodine-131 can induce liver...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
125I Brachytherapy Seeds Implantation for Inoperable Low-Grade Leiomyosarcoma of Inferior Vena Cava

Li Y, Wang Y, Liu B, Li Z, Wang W

A 60-year-old female presented with abdominal pain and tenderness of five-day duration. Contrast enhanced CT showed a mass of 9 x 6 x 5.5 cm in size with almost complete...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Partial remission with transarterial embolization in a case of metastatic adrenal cortical carcinoma

Koh MS, Lee MS, Hong SW, Lim D

A case of metastatic adrenal cortical carcinoma in which partial remission was achieved with transarterial embolization is presented as probably the first reported case in the literature to date. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer

Kairemo K, Kangasmäki A, Bom HS

The aim of this study was to compare radioactive iodine (I-131) biokinetics after recombinant human TSH stimulation (rhTSH) and thyroid hormone withdrawal (THW) in patients with differentiated thyroid cancer (DTC)....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Quality of Life and Related Factors in Thyroid Cancer Patients with Radioactive Iodine Remnant Ablation

Yoo SH, Choi-Kwon

PURPOSE: To investigate changes in Quality of life (QOL) and related factors in patients with thyroid cancer undergoing Radioactive Iodine remnant ablation (RAI). METHODS: Data were collected longitudinally 3 times for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis

Min SH, Phung A, Oh TJ, Han KS, Kim MJ, Kim JM, Lee JH, Park YJ

Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nodular hepatocellular carcinoma: treatment with intraarterial injection of I-131 Lipiodol

Yoo HS, Suh JH, Lee JT, Kim KW, Kim DI, Kim BS, Choi HJ, Lee KS

Twenty four patients with hepatocellular carcinoma who refused surgery or had unresectable tumor ranging 2.5 to 8.0 cm in size were treated with intrahepatic arterial injection of iodine-131-labeled iodized oil...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of P53 on the radiotherapy response of hepatocellular carcinoma

Gomes AR, Abrantes A, Brito AF, Laranjo M, Casalta-Lopes JE, Goncalves , Sarmento-Ribeiro AB, Botelho MF, Tralhao JG

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Estimates of Radiation Doses and Cancer Risk from Food Intake in Korea

Moon EK, Ha WH, Seo S, Jin YW, Jeong KH, Yoon HJ, Kim HS, Hwang MS, Choi H, Lee WJ

The aim of this study was to estimate internal radiation doses and lifetime cancer risk from food ingestion. Radiation doses from food intake were calculated using the Korea National Health...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Central Lymph Node Metastasis Is an Important Prognostic Factor in Patients with Papillary Thyroid Microcarcinoma

Lee J, Song Y, Soh EY

Papillary thyroid microcarcinoma (PTMC) has been increasing, without a consensus for the management of this condition. In the present study, we analyzed the clinicopathological features of patients with PTMC to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metastatic Follicular Thyroid Carcinoma to the Thymus in a 35-year-old Woman

Nam MS, Chu YC, Choe WS, Kim SJ, Hong SB, Kim YJ, Kim YS

Clinically detectable metastatic follicular thyroid carcinoma to the thymus is very rare in the literature and sometimes confused with false positive uptake of Iodine
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Theophylline Increases the Uptake of Radioiodine by Mouse Thyroid

Lee JM, Caturegli , Ladenson P

Diagnostic and therapeutic use of radioiodine in the management of thyroid disorders depends on the ability of thyroid cells to concentrate radioiodine, a process that is regulated by the intracellular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance of Observation without Repeated Radioiodine Therapy in Differentiated Thyroid Carcinoma Patients with Positive Surveillance Whole-Body Scans and Negative Thyroglobulin

Lim DJ, O JH, Kim MH, Kim JH, Kwon HS, Kim SH, Kang MI, Cha BY, Lee KW, Son HY

BACKGROUND/AIMS: Currently, there is no consensus on the necessity of repeated radioiodine therapy (RAI) in patients who show iodine uptake in the thyroid bed on a diagnostic whole-body scan (DxWBS)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer

Im M, Lee JK, Hong YJ, Hong SI, Kang HJ, Na II, Ryoo BY, Cheon GJ, Lee HN, Chang YH

Ionizing radiation including I131 might produce chromosomal translocation, causing hematologic malignancy. The incidence of leukemia following radioactive iodine treatment for thyroid cancer has been reported to be approximately 0.1 to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr